OpportunityTitle: Limited Competition - Women&apos;s Interagency HIV Study (WIHS-V) (U01)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following: U01 AI 35004, Bronx, NY (Montefiore Medical Center)  U01 AI 31834, Brooklyn, NY (SUNY Downstate Medical Center)  U01 AI 34993, Chicago, IL (Hektoen Institute for Medical Research)   U01 HD 32632, Los Angeles, CA (University of Southern California)  U01 AI 34989, San Francisco, CA (University of California - San Francisco)  U01 AI 34994, Washington, DC (Georgetown University)  U01 AI 42590, Baltimore, MD, (Johns Hopkins University) (as the WIHS Data Management and Analysis Center (WDMAC)  Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Description: The purpose of the Womens Interagency HIV Study V (WIHS-V) is to characterize the long-term, natural and treated history of HIV infection in the current cohort of women, and recruit and retain new women into the cohort to provide insight into the changing demographics of the HIV epidemic among women in the United States (U.S.) This Limited Competition Funding Opportunity Announcement (FOA) encourages applications from 1) current Clinical Research Sites (CRS), 2) the current Data Management and Analysis Center (WDMAC), and 3 new Clinical Research Site with capacity to enroll targeted populations of women from the Southern region of the U.S. (Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Mississippi, North Carolina, South Carolina, Tennessee, or Texas only). All cooperative agreement awards funded under this FOA will comprise the WIHS V epidemiologic cohort.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;